| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.2M | — | +0.0% |
| R&D Expense | $1.3M | -68.1% | -86.4% |
| SG&A Expense | $3.3M | +52.6% | -0.1% |
| Operating Income | -$4.6M | +26.5% | -573.8% |
| Income Tax | $0 | — | — |
| Net Income | -$4.2M | +26.3% | — |
| EPS (Basic) | -$0.06 | +62.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $33.1M | +188.1% | +114.4% |
| Current Assets | $33.6M | +180.9% | -0.2% |
| Total Assets | $34.5M | +178.3% | +0.1% |
| Current Liabilities | $3.1M | -57.2% | -72.0% |
| Total Liabilities | $3.6M | -51.4% | -68.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.6M | — | — |
| Capital Expenditures | $4K | — | — |
| Investing Cash Flow | $4.5M | — | — |
| Financing Cash Flow | $30.1M | — | — |
| Free Cash Flow | -$19.6M | — | — |
| — |
| EPS (Diluted) | -$0.06 | +62.5% | — |
| $30.9M |
| +511.9% |
| +33.5% |